CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 57 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $85,000 | +9.0% | 21,223 | 0.0% | 0.00% | – |
Q4 2018 | $78,000 | -57.1% | 21,223 | 0.0% | 0.00% | – |
Q3 2018 | $182,000 | -21.9% | 21,223 | 0.0% | 0.00% | – |
Q2 2018 | $233,000 | +51.3% | 21,223 | +58.8% | 0.00% | – |
Q1 2018 | $154,000 | +11.6% | 13,367 | 0.0% | 0.00% | – |
Q4 2017 | $138,000 | -37.6% | 13,367 | -3.6% | 0.00% | – |
Q3 2017 | $221,000 | +22.1% | 13,867 | -7.3% | 0.00% | – |
Q2 2017 | $181,000 | +28.4% | 14,967 | +121.2% | 0.00% | – |
Q1 2017 | $141,000 | +45.4% | 6,767 | 0.0% | 0.00% | – |
Q4 2016 | $97,000 | -15.7% | 6,767 | -2.9% | 0.00% | – |
Q3 2016 | $115,000 | +16.2% | 6,967 | 0.0% | 0.00% | – |
Q2 2016 | $99,000 | – | 6,967 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 3,101,709 | $7,475,000 | 1.50% |
ADAMS STREET PARTNERS LLC | 3,275,616 | $7,894,000 | 1.20% |
Telemetry Investments, L.L.C. | 192,909 | $465,000 | 0.60% |
CHI Advisors LLC | 400,000 | $964,000 | 0.32% |
Orbimed Advisors | 6,943,654 | $16,734,000 | 0.22% |
Ikarian Capital, LLC | 482,610 | $1,163,000 | 0.17% |
Anson Funds Management LP | 528,358 | $1,273,000 | 0.12% |
BVF INC/IL | 1,370,947 | $3,304,000 | 0.12% |
VR Adviser, LLC | 250,000 | $603,000 | 0.08% |
PURA VIDA INVESTMENTS, LLC | 492,384 | $1,187,000 | 0.04% |